Literature DB >> 16338973

eNOS translocation but not eNOS phosphorylation is dependent on intracellular Ca2+ in human atrial myocardium.

Christian Pott1, Dirk Steinritz, Birgit Bölck, Uwe Mehlhorn, Klara Brixius, Robert H G Schwinger, Wilhelm Bloch.   

Abstract

In endothelial cells, two ways of endothelial nitric oxide (NO) synthase (eNOS) activation are known: 1) translocation and 2) Akt-dependent phosphorylation of the enzyme at Ser(1177) (Ser(1177) eNOS). We have recently shown that agonist-induced Ser(1177) eNOS phosphorylation also occurs in human myocardium (10). In this study, we investigated the Ca(2+) dependency of these two mechanisms in human atrium. Therefore, atrial tissue was obtained from patients who underwent coronary artery bypass operations. In immunohistochemical experiments, the translocated form of eNOS and phosphorylated Ser(1177) eNOS were labeled using specific antibodies. eNOS translocation was measured in the absence and presence of the Ca(2+) chelator BAPTA before and after application of BRL 37344 (BRL), a beta(3)-adrenoceptor agonist that increases eNOS activity (34). In the absence of BAPTA, BRL time dependently increased the staining intensity of translocated eNOS, whereas in the presence of BAPTA, this effect was blunted. In contrast, BRL clearly increased the staining of phosphorylated Ser(1177) eNOS even in the presence of BAPTA. This observation was confirmed using Western blot analysis. Using the NO-sensitive dye diaminofluorescein, we have demonstrated that BRL induced a strong NO release. This effect was completely abolished in the presence of BAPTA but was unaffected by LY-292004, an inhibitor of phosphatidylinositol 3-kinase activity and eNOS phosphorylation. Although Ca(2+) dependent, neither the translocation of eNOS nor NO release was changed by the adenylate cyclase activator forskolin. In conclusion, 1) in human atrial myocardium, BRL-induced eNOS translocation but not Ser(1177) eNOS phosphorylation is dependent on intracellular Ca(2+). 2) In atrial myocardium, eNOS-translocation and not Ser(1177) eNOS phosphorylation is responsible for generating the main amount of NO. 3) Although Ca(2+) dependent, eNOS translocation and NO release could not be mimicked by adenylate cyclase activation as a mediator of beta-adrenergic stimulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338973     DOI: 10.1152/ajpcell.00005.2005

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  7 in total

Review 1.  [On the function of beta3-adrenoceptors in the human heart: signal transduction, inotropic effect and therapeutic prospects].

Authors:  Christian Pott; Dirk Steinritz; Andreas Napp; Wilhelm Bloch; Robert H G Schwinger; Klara Brixius
Journal:  Wien Med Wochenschr       Date:  2006-08

2.  G-protein-coupled receptor kinase interactor-1 (GIT1) is a new endothelial nitric-oxide synthase (eNOS) interactor with functional effects on vascular homeostasis.

Authors:  Songling Liu; Richard T Premont; Don C Rockey
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

3.  Functional role of HSP90 complexes with endothelial nitric-oxide synthase (eNOS) and calpain on nitric oxide generation in endothelial cells.

Authors:  Monica Averna; Roberto Stifanese; Roberta De Tullio; Mario Passalacqua; Franca Salamino; Sandro Pontremoli; Edon Melloni
Journal:  J Biol Chem       Date:  2008-08-05       Impact factor: 5.157

Review 4.  Nitric oxide synthases, S-nitrosylation and cardiovascular health: from molecular mechanisms to therapeutic opportunities (review).

Authors:  Adriana V Treuer; Daniel R Gonzalez
Journal:  Mol Med Rep       Date:  2014-11-18       Impact factor: 2.952

5.  Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity.

Authors:  Barbara Ludolph; Wilhelm Bloch; Malte Kelm; Rainer Schulz; Petra Kleinbongard
Journal:  Vasc Health Risk Manag       Date:  2007

6.  The genetic association between iNOS and eNOS polymorphisms and gastric cancer risk: a meta-analysis.

Authors:  Yi Zhu; Honggang Jiang; Zhiheng Chen; Bohao Lu; Jin Li; Yuping Peng; Xuning Shen
Journal:  Onco Targets Ther       Date:  2018-05-03       Impact factor: 4.147

7.  mTORc1 activity is necessary and sufficient for phosphorylation of eNOSS1177.

Authors:  Brandee Decker; Kevin Pumiglia
Journal:  Physiol Rep       Date:  2018-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.